| Nov 9 |
Artivion, Inc. (AORT) Q3 2024 Earnings Call Transcript
|
| Nov 9 |
Artivion Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 7 |
Artivion Non-GAAP EPS of $0.12 beats by $0.11, revenue of $95.8M beats by $1.04M
|
| Nov 7 |
Artivion Reports Third Quarter 2024 Financial Results
|
| Nov 5 |
Artivion to Participate in Upcoming Investor Conferences
|
| Oct 24 |
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results
|
| Oct 23 |
Artivion started at market outperform by JMP, stent graft devices cited
|
| Oct 10 |
Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
|
| Sep 26 |
Those who invested in Artivion (NYSE:AORT) a year ago are up 61%
|
| Aug 8 |
Artivion Non-GAAP EPS of $0.07 beats by $0.04, revenue of $98M beats by $0.4M
|
